RxDoctor Payments Data

Dantuluri Raju, MD

Adult Medicine · Ocala, FLNPI 1053316133

Payments from drug & device makers

$536in general payments, 2019–2025

Across 26 payments — averaging $20.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$116
  • Novartis$83
  • AstraZeneca$72
  • Sanofi-aventis U.S. LLC$61
  • Novo Nordisk$59
  • Pfizer$42
  • plus $104 from 5 others

What the payments were for

  • Food & beverage$536100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$536 in reported general payments places this provider in the 50th percentile of 195 adult medicine providers in Florida.

See all adult medicine providers in Florida

Medicare billing

Part B allowed, 2024
$74,807
Medicare patients
221
Services billed
727

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide28$37,773
EliquisApixaban33$29,273
JanuviaSitagliptin Phosphate21$28,056
MyrbetriqMirabegron19$22,395
MounjaroTirzepatide12$17,956
RexultiBrexpiprazole12$17,029
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,856
Breo ElliptaFluticasone/Vilanterol19$7,269
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl23$3,874
Rosuvastatin Calcium256$2,770
Omeprazole119$2,156
Valsartan87$2,048
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen59$1,933
Levothyroxine Sodium134$1,607
Gabapentin80$1,429

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$59$37,77328 claims
PfizerEliquis$42$29,27333 claims
MerckJanuvia$13$28,05621 claims
Astellas Pharma US IncMyrbetriq$22$22,39519 claims
Lilly USA, LLCMounjaro$19$17,95612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 195 adult medicine providers in Florida.

Other adult medicine in Ocala

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →